An emerging multi-omic understanding of the genetics of opioid addiction
Journal Article
·
· Journal of Clinical Investigation
- RTI International, Research Triangle Park, NC (United States)
- The Jackson Laboratory, Bar Harbor, ME (United States)
- Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)
- Massachusetts Institute of Technology (MIT), Cambridge, MA (United States)
- University of California San Diego, La Jolla, CA (United States); Vanderbilt University Medical Center, Nashville, TN (United States)
- University of California San Diego, La Jolla, CA (United States)
- Geisinger College of Health Sciences, Scranton, PA (United States)
- Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (United States)
Opioid misuse, addiction, and associated overdose deaths remain global public health crises. Despite the tremendous need for pharmacological treatments, current options are limited in number, use, and effectiveness. Fundamental leaps forward in our understanding of the biology driving opioid addiction are needed to guide development of more effective medication-assisted therapies. This Review focuses on the omics-identified biological features associated with opioid addiction. Recent GWAS have begun to identify robust genetic associations, including variants in OPRM1, FURIN, and the gene cluster SCAI/PPP6C/RABEPK. An increasing number of omics studies of postmortem human brain tissue examining biological features (e.g., histone modification and gene expression) across different brain regions have identified broad gene dysregulation associated with overdose death among opioid misusers. Drawn together by meta-analysis and multi-omic systems biology, and informed by model organism studies, key biological pathways enriched for opioid addiction–associated genes are emerging, which include specific receptors (e.g., GABAB receptors, GPCR, and Trk) linked to signaling pathways (e.g., Trk, ERK/MAPK, orexin) that are associated with synaptic plasticity and neuronal signaling. Studies leveraging the agnostic discovery power of omics and placing it within the context of functional neurobiology will propel us toward much-needed, field-changing breakthroughs, including identification of actionable targets for drug development to treat this devastating brain disease.
- Research Organization:
- Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)
- Sponsoring Organization:
- USDOE
- Grant/Contract Number:
- AC05-00OR22725
- OSTI ID:
- 2474759
- Journal Information:
- Journal of Clinical Investigation, Journal Name: Journal of Clinical Investigation Journal Issue: 20 Vol. 134; ISSN 1558-8238
- Publisher:
- American Society for Clinical InvestigationCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Multiomic Network Analysis Identifies Dysregulated Neurobiological Pathways in Opioid Addiction
Reducing opioid use disorder and overdose deaths in the United States: A dynamic modeling analysis
Activation of orexin-1 receptors in the amygdala enhances feeding in the diet-induced obesity rats: Blockade with μ-opioid antagonist
Journal Article
·
Thu Nov 28 19:00:00 EST 2024
· Biological Psychiatry
·
OSTI ID:2538461
Reducing opioid use disorder and overdose deaths in the United States: A dynamic modeling analysis
Journal Article
·
Thu Jun 23 20:00:00 EDT 2022
· Science Advances
·
OSTI ID:1905016
Activation of orexin-1 receptors in the amygdala enhances feeding in the diet-induced obesity rats: Blockade with μ-opioid antagonist
Journal Article
·
Sat Sep 15 00:00:00 EDT 2018
· Biochemical and Biophysical Research Communications
·
OSTI ID:23134239